By Rebecca Robbins and Gina Kolata from NYT Health https://ift.tt/kPhA0nD
via IFTTT
Health
Drugs (Pharmaceuticals), GLP-1 RAs (Drug), Diabetes, Weight, Prices (Fares, Fees and Rates), Clinical Trials, Obesity, Regulation and Deregulation of Industry, Ozempic (Drug)
New York Times
April 18, 2025 at 02:54AM
إرسال تعليق